Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ: RARE · Real-Time Price · USD
21.91
-1.40 (-6.01%)
At close: Jun 5, 2026, 4:00 PM EDT
22.34
+0.43 (1.96%)
After-hours: Jun 5, 2026, 7:57 PM EDT
Ultragenyx Pharmaceutical Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| J.P. Morgan | J.P. Morgan | Buy Maintains $74 → $72 | Buy | Maintains | $74 → $72 | +228.62% | May 23, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $84 → $96 | Buy | Reiterates | $84 → $96 | +338.16% | May 21, 2026 |
| Evercore ISI | Evercore ISI | Buy Maintains $34 → $33 | Buy | Maintains | $34 → $33 | +50.62% | May 11, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $79 | Buy | Maintains | $79 | +260.57% | May 11, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $50 | Buy | Reiterates | $50 | +128.21% | May 11, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $52 → $43 | Buy | Maintains | $52 → $43 | +96.26% | May 8, 2026 |
| Wedbush | Wedbush | Hold Maintains $27 → $26 | Hold | Maintains | $27 → $26 | +18.67% | May 8, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $68 | Buy | Maintains | $68 | +210.36% | May 7, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.